Total Funding
62
64
Total FundingPost-IPO Debt raised
Growth Score 62 in past quarter
1 pts
Heat Score 64 in past quarter
22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
104774
Mithra Pharmaceuticals specializes in the development of women's health care products.
- Leon Van Rompay: CEO
- François Fornieri: Owner
About the Company
Mithra Pharmaceuticals SA specializes in the development of women's health care products that are dedicated to the fields of contraception, fertility, and menopause. The two lead development candidates Estelle® (a fifth generation oral contraceptive) and Donesta® (a next generation hormone therapy) are built on Mithra's unique natural
estrogen platform, E4 (Estetrol).
